Advertisement

Topics

Threshold Pharmaceuticals Inc THLD Medical Equipment Deals and Alliances Profile. [Report Updated: 20072017] Prices from USD $250

03:41 EDT 9 Aug 2017 | BioPortfolio Reports

Summary

Threshold Pharmaceuticals Inc Threshold is a biotechnology company that discovers and develops tumourtargeted therapies. The company's clinical pipeline includes THCR406, MAESTRO, THCR413, THCR408, THIST4003, THIST4004, THCR410, THCR407 and THIST4001. Its products include evofosfamide, TH4000 and [18F]HX4. Threshold's evofosfamide and TH4000 are under evaluation for the treatment of a variety of tumor types. Threshold offers evofosfamide is a investigational hypoxiaactivated prodrug. The company's [18F]HX4 is an inlicensed positron emission tomography imaging agent for hypoxia. Its clinical trials are used in the treatment of diseases such as soft tissue sarcoma, pancreatic cancer, nonsquamous nonsmall cell lung cancer, advanced melanoma, multiple myeloma and advanced solid tumours, among others. The company operates in the US and Germany. Threshold is headquartered in South San Francisco, California, the US.

Threshold Pharmaceuticals Inc THLD Medical Equipment Deals and Alliances Profile. provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions.

GlobalData derived the data presented in this report from proprietary inhouse Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector.
Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios.
Business Description A brief description of the company's operations.
Key Employees A list of the key executives of the company.
Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors A list of the key competitors of the company.
Key Recent Developments A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay uptodate on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Original Article: Threshold Pharmaceuticals Inc THLD Medical Equipment Deals and Alliances Profile. [Report Updated: 20072017] Prices from USD $250

NEXT ARTICLE

More From BioPortfolio on "Threshold Pharmaceuticals Inc THLD Medical Equipment Deals and Alliances Profile. [Report Updated: 20072017] Prices from USD $250"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...